Comprehensive plasma metabolites profiling reveals phosphatidylcholine species as potential predictors for cardiac resynchronization therapy response-Reference-Cited by-同舟云学术

Comprehensive plasma metabolites profiling reveals phosphatidylcholine species as potential predictors for cardiac resynchronization therapy response

Published:2020-11-19 Issue:1 Volume:8 Page:280-290
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Yang Shengwen¹²,Hu Yiran¹,Zhao Junhan¹,Jing Ran¹,Wang Jing¹,Gu Min¹,Niu Hongxia¹,Chen Liang¹³,Hua Wei¹

Affiliation:

1. Arrhythmia Center, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College No. 167 Beilishi Road, Xicheng District Beijing 100037 China

2. Heart Center & Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital Capital Medical University Beijing 100020 China

3. Department of cardiac surgery,State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases Chinese Academy of Medical Sciences and Peking Union Medical College No. 167 Beilishi Road, Xicheng District Beijing 100037 China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13037

Reference43 articles.

1. Heart Disease and Stroke Statistics—2018 Update: A Report From the American Heart Association

2. Matrix Revisited

3. Targeted Metabolic Imaging to Improve the Management of Heart Disease